Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Realising the potential of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Immunogenicity of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Simplifying molecular subtypes of metastatic gastric cancer
Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain
Simplifying molecular subtypes of metastatic gastric cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )
8 Oct 2019
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma
Dr Jonathan Ledermann - University College Hospital, London, UK
ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma ( Dr Jonathan Ledermann - University College Hospital, London, UK )
7 Oct 2019
Optimal timing of radiotherapy following radical prostatectomy
Prof Chris Parker - The Royal Marsden Hospital, London, UK
Optimal timing of radiotherapy following radical prostatectomy ( Prof Chris Parker - The Royal Marsden Hospital, London, UK )
4 Oct 2019
Using PARP inhibitors to improve quality of life for patients with metastatic br...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
Using PARP inhibitors to improve quality of life for patients with metastatic breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
3 Oct 2019
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
Melanoma highlights from ESMO 2019 ( Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany )
30 Sep 2019
Ovarian highlights from ESMO 2019
Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA
Ovarian highlights from ESMO 2019 ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )
28 Sep 2019
Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma ( Prof Xavier Leleu - CHU la Miletrie, Poitiers, France )
25 Sep 2019
Real-world use of carfilzomib therapy among patients with existing cardiovascula...
Prof Xavier Leleu - CHU la Miletrie, Poitiers, France
Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history ( Prof Xavier Leleu - CHU la Miletrie, Poitiers, France )
25 Sep 2019
Transitioning from bortezomib to ixazomib in patients with multiple myeloma
Dr Habte Yimer - Texas Oncology, Tyler, USA
Transitioning from bortezomib to ixazomib in patients with multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )
23 Sep 2019